Preetpal Sidhu, Angel Investor

Preetpal Sidhu is CEO of BioPathogenix, a diagnostics company specializing in multiplex PCR and advanced laboratory testing. He previously founded and led Solaris Diagnostics, where he focused on clinical chemistry, toxicology, and pharmacogenomics, and earlier held leadership roles at Cal Laboratory. As an angel investor, Sidhu has supported OraLiva, a seed-stage diagnostics company pioneering AI-powered oral cytology technology for early detection of oral cancer and dysplasia. The company raised $2M in seed funding in October 2025, with Sidhu participating as a lead investor.